Article: Alpha-immunotherapy in cancer treatment. (Institute for Transuranium Elements develops radionuclide generator)

The Institute for Transuranium Elements (ITV; Karlsruhe, Germany) has developed radionuclide generators specially designed to produce alpha particle-emitting radionuclides for cancer therapy.

Alpha-immunotherapy uses bismuth-213 (Bi-213) attached to a monoclonal antibody which targets bone marrow, liver and spleen. The radionuclide delivers high-powered, short-range alpha particle radiation. Trials at the Memorial Sloan-Kettering Cancer Center (New York) have shown that alpha particles are 100 to 1,000 times more cytotoxic than beta particles and cause less damage to surrounding ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!